| Integrated genomic analyses of ovarian carcinoma Cancer Genome Atlas Research Network Nature 474 (7353), 609, 2011 | 6980 | 2011 |
| ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ... New England Journal of Medicine 363 (16), 1532-1543, 2010 | 1944 | 2010 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1818* | 2020 |
| Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome RW Tothill, AV Tinker, J George, R Brown, SB Fox, S Lade, DS Johnson, ... Clinical cancer research 14 (16), 5198-5208, 2008 | 1556 | 2008 |
| Whole–genome characterization of chemoresistant ovarian cancer AM Patch, EL Christie, D Etemadmoghadam, DW Garsed, J George, ... Nature 521 (7553), 489-494, 2015 | 1541 | 2015 |
| Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast Jr, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011 | 1532 | 2011 |
| BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian … K Alsop, S Fereday, C Meldrum, A DeFazio, C Emmanuel, J George, ... Journal of clinical oncology 30 (21), 2654-2663, 2012 | 1422 | 2012 |
| The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1 M Rozakis-Adcock, R Fernley, J Wade, T Pawson, D Bowtell Nature 363 (6424), 83-85, 1993 | 1303 | 1993 |
| Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015 | 1202 | 2015 |
| Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase MA Simon, DDL Bowtell, GS Dodson, TR Laverty, GM Rubin Cell 67 (4), 701-716, 1991 | 1035 | 1991 |
| The evolutionary history of 2,658 cancers M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ... Nature 578 (7793), 122-128, 2020 | 925 | 2020 |
| Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary AA Ahmed, D Etemadmoghadam, J Temple, AG Lynch, M Riad, ... The Journal of pathology 221 (1), 49-56, 2010 | 904 | 2010 |
| Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary SP Shah, M Köbel, J Senz, RD Morin, BA Clarke, KC Wiegand, G Leung, ... New England Journal of Medicine 360 (26), 2719-2729, 2009 | 868 | 2009 |
| Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types A Kilian, DDL Bowtell, HE Abud, GR Hime, DJ Venter, PK Keese, ... Human molecular genetics 6 (12), 2011-2019, 1997 | 835 | 1997 |
| Options available—from start to finish—for obtaining expression data by microarray DDL Bowtell Nature genetics 21 (1), 25-32, 1999 | 731 | 1999 |
| Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors MJ Peart, GK Smyth, RK Van Laar, DD Bowtell, VM Richon, PA Marks, ... Proceedings of the National Academy of Sciences 102 (10), 3697-3702, 2005 | 672 | 2005 |
| Prognostically relevant gene signatures of high-grade serous ovarian carcinoma RGW Verhaak, P Tamayo, JY Yang, D Hubbard, H Zhang, CJ Creighton, ... The Journal of clinical investigation 123 (1), 2012 | 657 | 2012 |
| Bcr‐Abl oncoproteins bind directly to activators of the Ras signalling pathway. L Puil, J Liu, G Gish, G Mbamalu, D Bowtell, PG Pelicci, R Arlinghaus, ... The EMBO journal 13 (4), 764-773, 1994 | 639 | 1994 |
| Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ... Nature genetics 52 (3), 331-341, 2020 | 572 | 2020 |
| 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG … A Du Bois, M Quinn, T Thigpen, J Vermorken, E Avall-Lundqvist, ... Annals of oncology 16, viii7-viii12, 2005 | 553 | 2005 |
